Literature DB >> 25286006

Differences in reaction specificity toward lipoprotein X and abnormal LDL among 6 homogeneous assays for LDL-cholesterol.

Kazumi Matsushima1, Hiroyuki Sugiuchi2, Kensaku Anraku1, Hitoshi Nishimura3, Masahiro Manabe3, Katsuyoshi Ikeda3, Yukio Ando3, Yuki Kondo4, Yoichi Ishitsuka4, Mitsuru Irikura4, Tetsumi Irie5.   

Abstract

BACKGROUND: We investigated the reaction specificity toward cholesterol in lipoprotein X (Lp-X) and abnormal LDL among 6 homogeneous assays for low-density lipoprotein cholesterol (LDL-C) based on different measurement principles.
METHODS: The homogeneous LDL-C assays used were based on the liquid selective detergent, selective solubilization, elimination, enzyme-selective protection, calixarene complex, and phosphate complex inhibition methods. The fraction with a density of 1.006-1.063 kg/l was isolated from cholestatic sera, and the reactivity of cholesterol in the lipoprotein fractions by gel filtration for each homogeneous LDL-C assay was determined.
RESULTS: The liquid selective detergent and elimination methods showed increased cholesterol reactivity in the Lp-X fraction in a concentration-dependent manner, while the selective solubilization and phosphate complex inhibition methods were less reactive toward Lp-X cholesterol. Meanwhile, the homogeneous LDL-C assays showed decreased reactivity against cholesterol in abnormal LDL, with increased ratios of phospholipids and triglycerides against cholesterol.
CONCLUSION: The homogeneous LDL-C assays showed differential reactivity toward Lp-X and abnormal LDL. Our findings enable accurate interpretation of the LDL-C values in these homogeneous assays, and suggest that these methods should be improved to distinguish between normal LDL and abnormal LDL or Lp-X.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abnormal LDL; Cholestasis; Homogeneous assays for LDL-cholesterol; Lecithin–cholesterol acyltransferase deficiency; Lipoprotein X; Reaction specificity

Mesh:

Substances:

Year:  2014        PMID: 25286006     DOI: 10.1016/j.cca.2014.09.030

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Detection of Lipoprotein X (LpX): A challenge in patients with severe hypercholesterolaemia.

Authors:  Agnieszka Ćwiklińska; Agnieszka Mickiewicz; Robert Kowalski; Barbara Kortas-Stempak; Agnieszka Kuchta; Krzysztof Mucha; Michał Makowiecki; Anna Gliwińska; Krzysztof Lewandowski; Leszek Pączek; Marcin Fijałkowski; Marcin Gruchała; Maciej Jankowski
Journal:  J Med Biochem       Date:  2020-09-02       Impact factor: 3.402

2.  Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.

Authors:  Takashi Miida; Kunihiro Nishimura; Satoshi Hirayama; Yoshihiro Miyamoto; Masakazu Nakamura; Daisaku Masuda; Shizuya Yamashita; Masaji Ushiyama; Toshiaki Komori; Naohisa Fujita; Shinji Yokoyama; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2017-03-17       Impact factor: 4.928

3.  Comparison of Two Homogeneous LDL-Cholesterol Assays Using Fresh Hypertriglyceridemic Serum and Quantitative Ultracentrifugation Fractions.

Authors:  Megumi Yano; Akira Matsunaga; Sadako Harada; Bo Zhang; Emi Kawachi; Mikiko Tadera; Keijiro Saku
Journal:  J Atheroscler Thromb       Date:  2019-03-19       Impact factor: 4.928

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.